Search results
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 24 hours agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 5 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 5 days agoThe findings were presented at the American Society of Clinical..., the data revealed that the...
Experimental therapy shows promise in pancreatic cancer clinical trial
Medical Xpress· 5 days agoIt acts by inflaming the microenvironment surrounding the tumor and thereby augmenting the activity...
Experimental Therapy Shows Promise in Pancreatic C | Newswise
Newswise· 7 days agoWASHINGTON --- Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic ...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 4 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 5 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 3 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...